BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 2694674)

  • 1. [Phenotypic analysis of human T-cell lymphoma with reference to cell differentiation and morphological classification].
    Feller AC
    Veroff Pathol; 1989; 131():1-175. PubMed ID: 2694674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversity of immunological phenotypes of lymphoblastic lymphoma.
    Cossman J; Chused TM; Fisher RI; Magrath I; Bollum F; Jaffe ES
    Cancer Res; 1983 Sep; 43(9):4486-90. PubMed ID: 6191861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunocytologic diagnosis of leukemia and lymphoma: monoclonal antibodies in the differential diagnosis of hematologic neoplasms].
    Huber H; Gattringer C; Thaler J; Peschel C
    Behring Inst Mitt; 1985 Dec; (78):83-117. PubMed ID: 3914283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic complexity of lymphoblastic lymphoma.
    Grogan T; Spier C; Wirt DP; Hicks MJ; Paquin M; Hutter J; Miller T; Rangel C; Richter L; Jones S
    Diagn Immunol; 1986; 4(2):81-8. PubMed ID: 3086016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
    Meusers P; Brittinger G
    Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
    Carbone A; Gloghini A; Gruss HJ; Pinto A
    Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and classification of hematologic tumors using anti-lymphocyte monoclonal antibodies].
    Kikuchi K
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):551-8. PubMed ID: 6603817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell receptor-CD3 complex during early T cell differentiation. Analysis of immature T cell acute lymphoblastic leukemias (T-ALL) at DNA, RNA, and cell membrane level.
    van Dongen JJ; Quertermous T; Bartram CR; Gold DP; Wolvers-Tettero IL; Comans-Bitter WM; Hooijkaas H; Adriaansen HJ; de Klein A; Raghavachar A
    J Immunol; 1987 Feb; 138(4):1260-9. PubMed ID: 3100631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)].
    Stein H
    Immun Infekt; 1976 Apr; 4(2):52-69. PubMed ID: 1085745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.
    Greaves MF
    Cancer Res; 1981 Nov; 41(11 Pt 2):4752-66. PubMed ID: 7028250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukemias and lymphomas of thymic differentiation.
    Borowitz MJ; Falletta JM
    Clin Lab Med; 1988 Mar; 8(1):119-34. PubMed ID: 2896085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunological classification of acute lymphoblastic leukemias (ALL) in childhood. Origin and clinical significance of phenotypic variability].
    Thöne I; Kabisch H; Müller J; Winkler K; Landbeck G
    Monatsschr Kinderheilkd; 1982 Dec; 130(12):883-90. PubMed ID: 6759928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Membrane receptors of lymphoreticular cells in hyperplastic and neoplastic diseases of the lymphatic system].
    Krüger G; Uhlmann C; Hellriegel KP; Sesterhenn K; Samii H; Fischer R; Wustrow F; Gross R
    Hamatol Bluttransfus; 1976; 18():17-29. PubMed ID: 1085715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
    Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
    Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of monoclonal antibodies, morphology, and cytochemistry to probe the cellular heterogeneity of acute leukemia and lymphoma.
    LeBien TW; McKenna RW; Abramson CS; Gajl-Peczalska KJ; Nesbit ME; Coccia PF; Bloomfield CD; Brunning RD; Kersey JH
    Cancer Res; 1981 Nov; 41(11 Pt 2):4776-80. PubMed ID: 6945905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides.
    Haynes BF; Bunn P; Mann D; Thomas C; Eisenbarth GS; Minna J; Fauci AS
    J Clin Invest; 1981 Feb; 67(2):523-30. PubMed ID: 6970206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of monoclonal antibodies to the characterization and diagnosis of lymphoid neoplasms: a review of recent studies.
    Knowles DM; Dodson LD; Raab R; Mittler RS; Talle MA; Goldstein G
    Diagn Immunol; 1983; 1(3):142-9. PubMed ID: 6333955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.